In Escherichia coli, plasmid DNA modified with N-2-aminofluorene adducts survived equally well in wild-type, uvrA, or uvrB strains. Increased sensitivity was found in uvrC and uvrD strains. Moreover, N-2-aminofluorene-mediated toxicity in the uvrC background was reversed when an additional uvrA mutation was introduced into the strain.
The Escherichia coli UvrABC endonuclease is known to be involved in the repair of DNA damage induced by UV irradiation (6, 11, 23, 25) or a large number of chemical agents (1, 10, 12, 19, 24) . This enzyme, termed excinuclease (12, 19) , is constituted by three subunits. UvrA binds weakly to DNA in an ATP-dependent manner, UvrB binds to UvrA and DNA to form a stable complex which scans the DNA (14, 20, 27) , and UvrC completes the excinuclease and is required in vitro for the incision step (26, 31) . In vitro studies have shown that the UvrABC ternary complex binds tightly to DNA and that detachment of the enzyme needs the presence of two other proteins, namely the uvrD and polA gene products (12, 13, 15) . It has also been demonstrated that the UvrABC complex incises a variety of DNA lesions such as UV dimers (6, 11, 23, 25) , psoralen-light lesions (19, 24) , cis-platinum adducts (1, 12) , and guanine adducts formed by covalent binding of carcinogenic N-2-aminofluorene derivatives' (10, 19) .
These derivatives lead to two types of C(8)-guanine adduct, namely, the acetylaminofluorene adduct (AAF) and its deacetylated form, the aminofluorene (AF) adduct. It is possible to generate one or the other type of adduct in vitro by using different reactive intermediates of the carcinogen. The conformation of DNA in the vicinity of AAF adducts has been described as the insertion-denaturation model (7, 8, 9) . In this model, the guanine is rotated from anti to syn with the concomitant insertion of the fluorene ring within the DNA helix. Local denaturation of the helix results frotn this conformational change (7, 8) . Binding of AAF to alternating GC or GT sequences leads to a B --X transition (16, 17, 21, 22, 30) . On the other hand, AF adducts bind to the C(8) of guanine residues without causing any major conformational change of the B-DNA structure (outside-binding model [4] efficiency, whereas AF adducts did not trigger this response (18) .
Taken together, these observations suggest two possible working hypotheses as far as the biological fate of AF adducts is concerned. (i) AF adducts, unlike AAF adducts, do not block the replication fork, and (ii) there is an efficient repair pathway for AF adducts different from the UvrABC pathway. Along these lines, it should be stressed that AF adducts were found to be toxic in uvrC strains but not in uvrA or uvrB strains (10, 29) . To study the potential role of uvrC gene function in the repair of AF adducts, we compared the transformation efficiencies of AF-modified plasmids in single (uvrA, uvrB, and uvrC) and double (uvrA-uvrC and uvrB-uvrC) mutant strains.
Plasmid pBR322 DNA was grown in strain AB1157 and purified as described previously (10) . Chemical modification of plasmid DNA with 3H-ring-labeled N-OH-AF and quantification of the extent of modification were determined as described previously (5, 10) . Wild-type strain AB1157 and isogenic Uvr-mutants AB1884 (uvrC34), AB1885 (uvrB5), AB1886 (uvrA6), AB2429 (uvrC34-uvrA37), and AB2430 (uvrC34-uvrB45) were originally isolated by HowardFlanders et al. (11) . Strain AB2429 (lambda uvrA+) was constructed by lysogenization of strain AB2429 with a lamnbda phage containing the uvrA' gene (a gift from R. Alazard). Strain NR3951 (AuvrB) was a gift from R. Schaaper, and ES549 (uvrD) was from E. Siegel (28) . E. coli cells were made competent for transformation by treatrhent with CaCl2 (3) . Transformants were selected on LB plates containing ampicillin (50 ,ug/ml).
Toxicity of AF adducts in uvrC strains is abolished in a strain carrying ajn additional uvrA mutation. Plasmid pBR322 DNA samples modified to various extents with AF adducts were transformed into various E. coli strains, and the relative transformation efficiencies were plotted as a function of the number of AF adducts per plasmid molecule (Fig.  1A) . The extent of modification at a relative transformation efficiency of 37% (i.e., corresponding to an average of one lethal hit per plasmid molecule) are given in Table 1 . Strains carrying the uvrA6, AuvrB, or uvrB5 allele produced results identical to those of the wild-type strain (i.e., =60 AF adducts at a 37% relative transformation efficiency), in agreement with previously reported results (11, 29) . On the other hand, the isogenic uvrC34 strain showed increased sensitivity toward AF-modified plasmid (37% relative transformation efficiency at 18 AF adducts per molecule) ( carrying the uvrC34 allele was suppressed when associated with the uvrA37 allele. In fact, in a strain carrying both the uvrC34 and uvrA37 alleles, AF-modified plasmids survived equally as well as in a Wild-type strain ( Fig. 1B; Table 1 ). To ascertain that this effect was really associated with the double mutattion, we constructd a phage lambda uvrA+ lysogen of this strain. The resulting uvrC34-uvrA37 lambda Construction of strain AB2429 (lambda uvrA +) is described in the text. Strain NR3951 (AuVrB) was a gift from R. Schaaper, and ES549 (uvrD) was from E. Siegel (28) . uvrA+ strain showed sensitivity toward AF-modified plasmid similar to that of the uvrC34 strain ( Fig. 1B; Table 1 ). The uvrC-associated toxicity toward AF adducts could not be rescued by the presence of a uvrB allele. In fact, a double (uvrC34-uvrB45) mutant strain exhibited sensitivity toward AF-modified plasmid similar to that observed in the uvrC background. A strain carrying a uvrD mutation showed a response toward AF adducts similar to that observed in a uvrC strain (Fig. 1B, Table 1 ).
These observations tend to rule out the possibility of an active role of the uvrC gene product in the repair of AF adducts other than its known role as part of the UvrAI3C excinuclease but point out that the toxicity that was observed in uvrC strains was due to impaired functioning of the mutant form of the UvrABC excinuclease (i.e., the excinuclease containing the mutant form of the UvrC protein). In vitro experiments have shown that AF-modified plasmid is a substrate for the purified UvrABC excinuclease (10) . Since AF-modified plasmids transformed uvrA and wild-type strains equally well, it was concluded that in vivo UvrABC-mpdiated excision repair of AF adducts is not useful for survival of the modified plasmids (10) . An explanation for the toxcicity of AF adducts in the uvrC strain might be that, like the wild-type UvrABC excinuclease, its mutant form (i.e., in the uvrC strain) is able to bind at the site of AF adducts. Although the molecular basis of the toxicity is unknown, two models can be proposed. (i) The mutant form of the excinuclease creates abnormal breaks in the vicinity of the lesion. This hypothesis is supported by the observation of slow accumulation of single-strand breaks in a UVirradiated uvrC strain (26) . These breaks can be qualified as abnormal since they are not repaired in the presence of an active polA allele (26) . (ii) The mutant excinuclease is such that it cannot be detached from its binding site, thus creating a block to the replication machinery. Husain et. al. (13) have recently demonstrated in vitro that turnover of the UvrABC excinuclease needs active participation of both the uvrD and the polI gene products. They propose that the uvrD gene product (i.e., helicase II) is necessary for release of the UvrC protein and that the combined action of PolA and UvrD proteins acts to dissociate the remaining complex. This model would also account for the high sensitivity toward AF adducts that is observed in uvrD strains.
To account for the different results obtained in the double uvr-strains (uvrC34-uvrB45 and uvrC34-uvrA37), one can suggest that the mutated UvrABC excinuclease present in the former strain (UvrA+B-C-) is still able to bind to its DNA substrate, thus creating a block to replication, whereas in the latter strain the mutated UvrA-B+C-excinuclease is unable to bind to DNA. This might reflect the fact that the UvrA protein is a DNA-binding protein, whereas UvrB is not.
In conclusion, one might speculate that (i) the uvrC gene product does not play an active role in repair of AF adducts, and (ii) impaired functioning of the mutated form of the UvrABC excinuclease bound to AF adducts containing DNA creates a lesion that blocks replication.
Therefore, we stress that increased sensitivity of a mutant strain when transformed with a plasmid containing a given type of lesion does not necessarily imply that the mutated gene has a specific function in the repair of that lesion.
